Skip to content

SDS Surgery

Active Private limited companyfounded 2024active for 2 yearsBrouwersstraat 18, 9000 GhentKBO/BCE: BE 1005.612.262

Lifetime

2 annual accounts with figures on one time axis
peak of €227,323 in 2025
€227,323▲ 23.6%
peak of €105,494 in 2025
€105,494▲ 10.2%
peak of €204,264 in 2025
€204,264▲ 107%
€432,092▼ 20.7%
Board1 name since 2024
1 director
Documentsfilings and deeds
31-08-202631 days late
2025micro format
Gross margin from €183,905 to €227,323Equity from €98,770 to €204,264Debts from €544,786 to €432,092

Key points

from the 2025 annual accounts

Equity

€204,264 ▲ 107%
€98,8002024€204,0002025

Equity rose in 2025 from €98,770 to €204,264.

Turnover

≈ €420,000 estimated

The micro format states no turnover.

Liquidity

1.57 was 1.00 in 2024

Short-term debts fell from €233,974 to €182,134.

2025 accounts filed 31 days after the deadline

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 39,332 companies had the same profile as SDS Surgery has now. Each dot stands for 99 companies, two years later.

95.7%
were still trading
2.4%
stopped another way
1.8%
went bankrupt
  • Micro
  • 2 to 5 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,994 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 39,332 companies, not a prediction for SDS Surgery. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 05-02-2024
  • 100 sharesdeed of 07-02-2024
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:1005612262
Incorporation Founding capital of €3,000, 100 shares · Founded by · 100 shares · published on 07-02-2024 · Gazette deed
First establishment Brouwersstraat 18, Ghent
All 6 events

Comparable companies

same main activity, similar in size and age
Company
SDS Surgery Ghent €636,355 €227,323 32.1% -
Medische Praktijk Neurologie GL Ghent €641,022 €245,257 79.8% -
Interventional Psychiatry Bonheiden €634,564 €207,093 21.8% -
PVO Verviers €647,298 €261,359 63.6% -
Cabinet médical Dr R.M. Namur €572,897 €209,911 58.3% -
Dokter Vinke Geel €567,057 €252,013 59.9% -
AWGF Oudenaarde €664,273 €280,078 67.2% -

These companies have the same main activity as SDS Surgery: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €567,000 and €664,000, founded between 2023 and 2024.

Official details

Source: KBO
Status
Active since 05-02-2024Normal situation
Activity
Specialist medical practiceNACE 86220
Joint committee
330.04Health institutions and services · annual accounts 2025
Establishment unit
2.356.663.4019000 Ghent, since 05-02-2024
Financial year end
31 December
Peppol
Reachable since 02-09-2025
Company details

Annual accounts 2025

€636,355▼ 1.1%
Employeeson 31-12-2025
1
Filing
Filed on 31-08-2026
Financials

Insights on SDS Surgery

SDS Surgery has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €204,264 and a net result of €105,494.

Its solvency ranks better than 27% of 21,373 sector peers (NACE 86) in financial year 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about SDS Surgery

What is the company number of SDS Surgery?
The company number of SDS Surgery is 1005.612.262. The VAT number is the same number with BE in front: BE 1005.612.262.
Where is SDS Surgery based?
The registered office is at Brouwersstraat 18, 9000 Ghent.Company details
What does SDS Surgery do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of SDS Surgery?
SDS Surgery is a private limited company (BV).
When was SDS Surgery founded?
SDS Surgery was founded on 05-02-2024.
Is SDS Surgery still active?
Yes, SDS Surgery is an active enterprise in the KBO register.
How many employees does SDS Surgery have?
SDS Surgery had an average of 1 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does SDS Surgery fall under?
In its 2025 annual accounts, SDS Surgery states joint committee 330.04 (Health institutions and services).
What is the turnover of SDS Surgery?
The turnover in financial year 2025 is about €420,000. This figure is estimated from the gross margin of €227,323 and 40 comparable companies (NACE 86220). It probably lies between €360,000 and €560,000.
Is SDS Surgery profitable?
In financial year 2025, SDS Surgery made a profit of €105,494.
Where can I find the annual accounts of SDS Surgery?
SDS Surgery filed 2 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of SDS Surgery due?
SDS Surgery must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.